With the exception of CpG7, the CpGs targeted in the ABCG2 promoter were methylated (methylation status ≥ 5%) in at least 14 out of the 16 tumor, tumor-adjacent and tumor-distant tissues (Figure 7B). The gene discussed is ABCG2; the disease is neoplasm.